カテゴリー： GlobalInfoResearch, 世界

DTC病気リスクおよび健康診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Direct-to-consumer Disease Risk and Health Test Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102765）・商品コード：GIR9102765
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月23日（※2024年版があります。お問い合わせください）
・ページ数：138
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、DTC病気リスクおよび健康診断の世界市場について調べ、まとめました。種類別セグメントは、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。DTC病気リスクおよび健康診断の世界市場概観、企業動向、企業別DTC病気リスクおよび健康診断シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・DTC病気リスクおよび健康診断の市場概観
・DTC病気リスクおよび健康診断の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・DTC病気リスクおよび健康診断の企業別販売動向、市場シェア、市場集中度、競争動向
・DTC病気リスクおよび健康診断の世界市場規模
・DTC病気リスクおよび健康診断の北米市場分析（アメリカ、カナダ、メキシコ等）
・DTC病気リスクおよび健康診断のアメリカ市場規模推移
・DTC病気リスクおよび健康診断のカナダ市場規模推移
・DTC病気リスクおよび健康診断のメキシコ市場規模推移
・DTC病気リスクおよび健康診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・DTC病気リスクおよび健康診断のドイツ市場規模推移
・DTC病気リスクおよび健康診断のイギリス市場規模推移
・DTC病気リスクおよび健康診断のロシア市場規模推移
・DTC病気リスクおよび健康診断のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・DTC病気リスクおよび健康診断の日本市場規模推移
・DTC病気リスクおよび健康診断の中国市場規模推移
・DTC病気リスクおよび健康診断の韓国市場規模推移
・DTC病気リスクおよび健康診断のインド市場規模推移
・DTC病気リスクおよび健康診断の東南アジア市場規模推移
・DTC病気リスクおよび健康診断の南米市場分析（ブラジル、アルゼンチン等）
・DTC病気リスクおよび健康診断の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・DTC病気リスクおよび健康診断の種類別分析/販売量、売上、市場シェア（セリアック病、パーキンソン病、アルツハイマー病、その他）
・DTC病気リスクおよび健康診断の用途別分析/市場規模（オンライン、オフライン）
・DTC病気リスクおよび健康診断の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・DTC病気リスクおよび健康診断の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.

Scope of the Report:
The global Direct-to-consumer Disease Risk and Health Test market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Direct-to-consumer Disease Risk and Health Test.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Direct-to-consumer Disease Risk and Health Test market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Direct-to-consumer Disease Risk and Health Test market by product type and applications/end industries.

Market Segment by Companies, this report covers
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Celiac Disease
Parkinson Disease
Alzheimer Disease
Other

Market Segment by Applications, can be divided into
Online
Offline

【レポートの目次】

Table of Contents

1 Direct-to-consumer Disease Risk and Health Test Market Overview
1.1 Product Overview and Scope of Direct-to-consumer Disease Risk and Health Test
1.2 Classification of Direct-to-consumer Disease Risk and Health Test by Types
1.2.1 Global Direct-to-consumer Disease Risk and Health Test Revenue Comparison by Types (2019-2024)
1.2.2 Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Types in 2018
1.2.3 Celiac Disease
1.2.4 Parkinson Disease
1.2.5 Alzheimer Disease
1.2.6 Other
1.3 Global Direct-to-consumer Disease Risk and Health Test Market by Application
1.3.1 Global Direct-to-consumer Disease Risk and Health Test Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Online
1.3.3 Offline
1.4 Global Direct-to-consumer Disease Risk and Health Test Market by Regions
1.4.1 Global Direct-to-consumer Disease Risk and Health Test Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Direct-to-consumer Disease Risk and Health Test Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Direct-to-consumer Disease Risk and Health Test Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Direct-to-consumer Disease Risk and Health Test Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Direct-to-consumer Disease Risk and Health Test Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Direct-to-consumer Disease Risk and Health Test Status and Prospect (2014-2024)
1.5 Global Market Size of Direct-to-consumer Disease Risk and Health Test (2014-2024)
2 Manufacturers Profiles
2.1 23andMe
2.1.1 Business Overview
2.1.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.2 MyHeritage
2.2.1 Business Overview
2.2.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.3 LabCorp
2.3.1 Business Overview
2.3.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.4 Myriad Genetics
2.4.1 Business Overview
2.4.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.5 Ancestry.com
2.5.1 Business Overview
2.5.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.6 Quest Diagnostics
2.6.1 Business Overview
2.6.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.7 Gene By Gene
2.7.1 Business Overview
2.7.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.8 DNA Diagnostics Center
2.8.1 Business Overview
2.8.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.9 Invitae
2.9.1 Business Overview
2.9.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.10 IntelliGenetics
2.10.1 Business Overview
2.10.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.11 Ambry Genetics
2.11.1 Business Overview
2.11.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.12 Living DNA
2.12.1 Business Overview
2.12.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.13 EasyDNA
2.13.1 Business Overview
2.13.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.14 Pathway Genomics
2.14.1 Business Overview
2.14.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.15 Centrillion Technology
2.15.1 Business Overview
2.15.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.16 Xcode
2.16.1 Business Overview
2.16.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.17 Color Genomics
2.17.1 Business Overview
2.17.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.18 Anglia DNA Services
2.18.1 Business Overview
2.18.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.19 African Ancestry
2.19.1 Business Overview
2.19.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.20 Canadian DNA Services
2.20.1 Business Overview
2.20.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.21 DNA Family Check
2.21.1 Business Overview
2.2.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.22 Alpha Biolaboratories
2.22.1 Business Overview
2.22.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.23 Test Me DNA
2.23.1 Business Overview
2.23.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.24 23 Mofang
2.24.1 Business Overview
2.24.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.25 Genetic Health
2.25.1 Business Overview
2.25.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.26 DNA Services of America
2.26.1 Business Overview
2.26.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.27 Shuwen Health Sciences
2.27.1 Business Overview
2.27.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.28 Mapmygenome
2.28.1 Business Overview
2.28.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
2.29 Full Genomes
2.29.1 Business Overview
2.29.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
3 Global Direct-to-consumer Disease Risk and Health Test Market Competition, by Players
3.1 Global Direct-to-consumer Disease Risk and Health Test Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Direct-to-consumer Disease Risk and Health Test Players Market Share
3.2.2 Top 10 Direct-to-consumer Disease Risk and Health Test Players Market Share
3.3 Market Competition Trend
4 Global Direct-to-consumer Disease Risk and Health Test Market Size by Regions
4.1 Global Direct-to-consumer Disease Risk and Health Test Revenue and Market Share by Regions
4.2 North America Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
4.3 Europe Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
4.5 South America Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
5 North America Direct-to-consumer Disease Risk and Health Test Revenue by Countries
5.1 North America Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
5.2 USA Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
5.3 Canada Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
5.4 Mexico Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
6 Europe Direct-to-consumer Disease Risk and Health Test Revenue by Countries
6.1 Europe Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
6.2 Germany Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
6.3 UK Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
6.4 France Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
6.5 Russia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
6.6 Italy Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue by Countries
7.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
7.2 China Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
7.3 Japan Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
7.4 Korea Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
7.5 India Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
8 South America Direct-to-consumer Disease Risk and Health Test Revenue by Countries
8.1 South America Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
8.2 Brazil Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
8.3 Argentina Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
8.4 Colombia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Direct-to-consumer Disease Risk and Health Test by Countries
9.1 Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
9.2 Saudi Arabia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
9.3 UAE Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
9.4 Egypt Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
9.5 Nigeria Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
9.6 South Africa Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
10 Global Direct-to-consumer Disease Risk and Health Test Market Segment by Type
10.1 Global Direct-to-consumer Disease Risk and Health Test Revenue and Market Share by Type (2014-2019)
10.2 Global Direct-to-consumer Disease Risk and Health Test Market Forecast by Type (2019-2024)
10.3 Celiac Disease Revenue Growth Rate (2014-2024)
10.4 Parkinson Disease Revenue Growth Rate (2014-2024)
10.5 Alzheimer Disease Revenue Growth Rate (2014-2024)
10.6 Other Revenue Growth Rate (2014-2024)
11 Global Direct-to-consumer Disease Risk and Health Test Market Segment by Application
11.1 Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2014-2019)
11.2 Direct-to-consumer Disease Risk and Health Test Market Forecast by Application (2019-2024)
11.3 Online Revenue Growth (2014-2019)
11.4 Offline Revenue Growth (2014-2019)
12 Global Direct-to-consumer Disease Risk and Health Test Market Size Forecast (2019-2024)
12.1 Global Direct-to-consumer Disease Risk and Health Test Market Size Forecast (2019-2024)
12.2 Global Direct-to-consumer Disease Risk and Health Test Market Forecast by Regions (2019-2024)
12.3 North America Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
12.4 Europe Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
12.6 South America Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Direct-to-consumer Disease Risk and Health Test Picture
Table Product Specifications of Direct-to-consumer Disease Risk and Health Test
Table Global Direct-to-consumer Disease Risk and Health Test and Revenue (Million USD) Market Split by Product Type
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Types in 2018
Figure Celiac Disease Picture
Figure Parkinson Disease Picture
Figure Alzheimer Disease Picture
Figure Other Picture
Table Global Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) by Application (2014-2024)
Figure Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Applications in 2018
Figure Online Picture
Figure Offline Picture
Table Global Market Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) and Growth Rate (2014-2024)
Table 23andMe Basic Information, Manufacturing Base and Competitors
Table 23andMe Direct-to-consumer Disease Risk and Health Test Type and Applications
Table 23andMe Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table MyHeritage Basic Information, Manufacturing Base and Competitors
Table MyHeritage Direct-to-consumer Disease Risk and Health Test Type and Applications
Table MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table LabCorp Basic Information, Manufacturing Base and Competitors
Table LabCorp Direct-to-consumer Disease Risk and Health Test Type and Applications
Table LabCorp Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table Myriad Genetics Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Ancestry.com Basic Information, Manufacturing Base and Competitors
Table Ancestry.com Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Gene By Gene Basic Information, Manufacturing Base and Competitors
Table Gene By Gene Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table DNA Diagnostics Center Basic Information, Manufacturing Base and Competitors
Table DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Type and Applications
Table DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Invitae Basic Information, Manufacturing Base and Competitors
Table Invitae Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Invitae Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table IntelliGenetics Basic Information, Manufacturing Base and Competitors
Table IntelliGenetics Direct-to-consumer Disease Risk and Health Test Type and Applications
Table IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Ambry Genetics Basic Information, Manufacturing Base and Competitors
Table Ambry Genetics Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Living DNA Basic Information, Manufacturing Base and Competitors
Table Living DNA Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Living DNA Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table EasyDNA Basic Information, Manufacturing Base and Competitors
Table EasyDNA Direct-to-consumer Disease Risk and Health Test Type and Applications
Table EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Pathway Genomics Basic Information, Manufacturing Base and Competitors
Table Pathway Genomics Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Centrillion Technology Basic Information, Manufacturing Base and Competitors
Table Centrillion Technology Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Xcode Basic Information, Manufacturing Base and Competitors
Table Xcode Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Xcode Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Color Genomics Basic Information, Manufacturing Base and Competitors
Table Color Genomics Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Anglia DNA Services Basic Information, Manufacturing Base and Competitors
Table Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table African Ancestry Basic Information, Manufacturing Base and Competitors
Table African Ancestry Direct-to-consumer Disease Risk and Health Test Type and Applications
Table African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Canadian DNA Services Basic Information, Manufacturing Base and Competitors
Table Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table DNA Family Check Basic Information, Manufacturing Base and Competitors
Table DNA Family Check Direct-to-consumer Disease Risk and Health Test Type and Applications
Table DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Alpha Biolaboratories Basic Information, Manufacturing Base and Competitors
Table Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Test Me DNA Basic Information, Manufacturing Base and Competitors
Table Test Me DNA Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table 23 Mofang Basic Information, Manufacturing Base and Competitors
Table 23 Mofang Direct-to-consumer Disease Risk and Health Test Type and Applications
Table 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Genetic Health Basic Information, Manufacturing Base and Competitors
Table Genetic Health Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table DNA Services of America Basic Information, Manufacturing Base and Competitors
Table DNA Services of America Direct-to-consumer Disease Risk and Health Test Type and Applications
Table DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Shuwen Health Sciences Basic Information, Manufacturing Base and Competitors
Table Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Mapmygenome Basic Information, Manufacturing Base and Competitors
Table Mapmygenome Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Full Genomes Basic Information, Manufacturing Base and Competitors
Table Full Genomes Direct-to-consumer Disease Risk and Health Test Type and Applications
Table Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
Table Global Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) by Players (2014-2019)
Table Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Players (2014-2019)
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Players in 2017
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Players in 2018
Figure Global Top 5 Players Direct-to-consumer Disease Risk and Health Test Revenue Market Share in 2018
Figure Global Top 10 Players Direct-to-consumer Disease Risk and Health Test Revenue Market Share in 2018
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) by Regions (2014-2019)
Table Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Regions (2014-2019)
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Regions (2014-2019)
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Regions in 2018
Figure North America Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Europe Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure South America Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table North America Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
Table North America Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure North America Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure North America Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries in 2018
Figure USA Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Canada Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Mexico Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table Europe Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) by Countries (2014-2019)
Figure Europe Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure Europe Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries in 2018
Figure Germany Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure UK Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure France Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Russia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Italy Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries in 2018
Figure China Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Japan Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Korea Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure India Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table South America Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
Table South America Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure South America Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure South America Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries in 2018
Figure Brazil Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Argentina Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Colombia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Countries in 2018
Figure Saudi Arabia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure UAE Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Egypt Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure Nigeria Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Figure South Africa Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
Table Global Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) by Type (2014-2019)
Table Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Type (2014-2019)
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Type (2014-2019)
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Type in 2019
Table Global Direct-to-consumer Disease Risk and Health Test Revenue Forecast by Type (2019-2024)
Figure Global Direct-to-consumer Disease Risk and Health Test Market Share Forecast by Type (2019-2024)
Figure Global Celiac Disease Revenue Growth Rate (2014-2019)
Figure Global Parkinson Disease Revenue Growth Rate (2014-2019)
Figure Global Alzheimer Disease Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Direct-to-consumer Disease Risk and Health Test Revenue by Application (2014-2019)
Table Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Application (2014-2019)
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Application (2014-2019)
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Application in 2019
Table Global Direct-to-consumer Disease Risk and Health Test Revenue Forecast by Application (2019-2024)
Figure Global Direct-to-consumer Disease Risk and Health Test Market Share Forecast by Application (2019-2024)
Figure Global Online Revenue Growth Rate (2014-2019)
Figure Global Offline Revenue Growth Rate (2014-2019)
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Direct-to-consumer Disease Risk and Health Test Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
Figure Europe Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
Figure South America Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)


【掲載企業】

23andMe、MyHeritage、LabCorp、Myriad Genetics、Ancestry.com、Quest Diagnostics、Gene By Gene、DNA Diagnostics Center、Invitae、IntelliGenetics、Ambry Genetics、Living DNA、EasyDNA、Pathway Genomics、Centrillion Technology、Xcode、Color Genomics、Anglia DNA Services、African Ancestry、Canadian DNA Services、DNA Family Check、Alpha Biolaboratories、Test Me DNA、23 Mofang、Genetic Health、DNA Services of America、Shuwen Health Sciences、Mapmygenome、Full Genomes、

★調査レポート[DTC病気リスクおよび健康診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102765)販売に関する免責事項を必ずご確認ください。
★調査レポート[DTC病気リスクおよび健康診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 消費者への直接的な疾病リスクと健康DNA検査の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102767 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、消費者への直接的な疾病リスクと健康DNA検査の世界市場について調べ、まとめました。種類別セグメントは、I型、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。消費者への直接的な疾病リスクと健康DNA検査の世界市場概観、メーカー動向、メーカー別消費者への直接的な疾病リスクと健康DNA検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・消費者への直接的な疾病リスクと健康DNA検査の市場概観 ・消費者への直接的な疾病リスクと健康DNA検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・消費者への直接的な疾病リスクと健康DNA検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・消費者への直接的な疾病リスクと健康DNA検査の世界市場規模 ・消費者への直接的な疾病リスクと健康DNA検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・消費者への直接的な疾病リスクと健康DNA検査のアメリカ市場規模推移 ・消費者への直接的な疾病リスクと健康DNA検査のカナダ市場規模推移 ・消費者への直接的な疾病リスクと健康DNA検査のメキシコ市場規模推移 ・消費者への直接的な疾病リスクと健康DNA検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The worldwide market for Direct-to-consumer Disease Risk and Health DNA Test is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in...
  • DTC病気リスクおよび健康の遺伝学的検査の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102766 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、DTC病気リスクおよび健康の遺伝学的検査の世界市場について調べ、まとめました。種類別セグメントは、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。DTC病気リスクおよび健康の遺伝学的検査の世界市場概観、メーカー動向、メーカー別DTC病気リスクおよび健康の遺伝学的検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・DTC病気リスクおよび健康の遺伝学的検査の市場概観 ・DTC病気リスクおよび健康の遺伝学的検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・DTC病気リスクおよび健康の遺伝学的検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・DTC病気リスクおよび健康の遺伝学的検査の世界市場規模 ・DTC病気リスクおよび健康の遺伝学的検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・DTC病気リスクおよび健康の遺伝学的検査のアメリカ市場規模推移 ・DTC病気リスクおよび健康の遺伝学的検査のカナダ市場規模推移 ・DTC病気リスクおよび健康の遺伝学的検査のメキシコ市場規模推移 ・DTC病気リスクおよび健康の遺伝学的検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The worldwide market for Direct-to-consumer Disease Risk and Health Genetic Test is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in...
  • 病気リスクおよび健康診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102763 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、病気リスクおよび健康診断の世界市場について調べ、まとめました。種類別セグメントは、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。病気リスクおよび健康診断の世界市場概観、企業動向、企業別病気リスクおよび健康診断シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・病気リスクおよび健康診断の市場概観 ・病気リスクおよび健康診断の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・病気リスクおよび健康診断の企業別販売動向、市場シェア、市場集中度、競争動向 ・病気リスクおよび健康診断の世界市場規模 ・病気リスクおよび健康診断の北米市場分析（アメリカ、カナダ、メキシコ等） ・病気リスクおよび健康診断のアメリカ市場規模推移 ・病気リスクおよび健康診断のカナダ市場規模推移 ・病気リスクおよび健康診断のメキシコ市場規模推移 ・病気リスクおよび健康診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The global Disease Risk and Health Test market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and...
  • 疾病リスクおよび健康遺伝子検査の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102762 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、疾病リスクおよび健康遺伝子検査の世界市場について調べ、まとめました。種類別セグメントは、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。疾病リスクおよび健康遺伝子検査の世界市場概観、企業動向、企業別疾病リスクおよび健康遺伝子検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・疾病リスクおよび健康遺伝子検査の市場概観 ・疾病リスクおよび健康遺伝子検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・疾病リスクおよび健康遺伝子検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・疾病リスクおよび健康遺伝子検査の世界市場規模 ・疾病リスクおよび健康遺伝子検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・疾病リスクおよび健康遺伝子検査のアメリカ市場規模推移 ・疾病リスクおよび健康遺伝子検査のカナダ市場規模推移 ・疾病リスクおよび健康遺伝子検査のメキシコ市場規模推移 ・疾病リスクおよび健康遺伝子検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The global Disease Risk and Health Genetic Test market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019...
  • 病気リスクおよび健康DNA検査の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102764 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、病気リスクおよび健康DNA検査の世界市場について調べ、まとめました。種類別セグメントは、セリアック病、パーキンソン病、アルツハイマー病、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。病気リスクおよび健康DNA検査の世界市場概観、メーカー動向、メーカー別病気リスクおよび健康DNA検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・病気リスクおよび健康DNA検査の市場概観 ・病気リスクおよび健康DNA検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・病気リスクおよび健康DNA検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・病気リスクおよび健康DNA検査の世界市場規模 ・病気リスクおよび健康DNA検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・病気リスクおよび健康DNA検査のアメリカ市場規模推移 ・病気リスクおよび健康DNA検査のカナダ市場規模推移 ・病気リスクおよび健康DNA検査のメキシコ市場規模推移 ・病気リスクおよび健康DNA検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The worldwide market for Disease Risk and Health DNA Test is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019,...
  • 鎌状赤血球症診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101229 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、鎌状赤血球症診断の世界市場について調べ、まとめました。種類別セグメントは、テストサービス、テストキット等、用途別セグメントは、新生児、大人等に区分しました。鎌状赤血球症診断の世界市場概観、企業動向、企業別鎌状赤血球症診断シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・鎌状赤血球症診断の市場概観 ・鎌状赤血球症診断の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・鎌状赤血球症診断の企業別販売動向、市場シェア、市場集中度、競争動向 ・鎌状赤血球症診断の世界市場規模 ・鎌状赤血球症診断の北米市場分析（アメリカ、カナダ、メキシコ等） ・鎌状赤血球症診断のアメリカ市場規模推移 ・鎌状赤血球症診断のカナダ市場規模推移 ・鎌状赤血球症診断のメキシコ市場規模推移 ・鎌状赤血球症診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Sickle Cell Disease Diagnosis market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sickle Cell Disease Diagnosis. Europe also play important...
  • DTC関係DNA検査の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102761 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、DTC関係DNA検査の世界市場について調べ、まとめました。種類別セグメントは、兄弟DNA検査、祖父母検査、遺伝子再構成検査、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。DTC関係DNA検査の世界市場概観、企業動向、企業別DTC関係DNA検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・DTC関係DNA検査の市場概観 ・DTC関係DNA検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・DTC関係DNA検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・DTC関係DNA検査の世界市場規模 ・DTC関係DNA検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・DTC関係DNA検査のアメリカ市場規模推移 ・DTC関係DNA検査のカナダ市場規模推移 ・DTC関係DNA検査のメキシコ市場規模推移 ・DTC関係DNA検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests can indicate whether tested individuals are biologically related to one another. For example, kinship testing can establish whether one person is the biological father of another (paternity testing). Scope of the Report: The global Direct-to-consumer Relationship DNA Tests market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially...
  • DTC関係検査の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102759 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、DTC関係検査の世界市場について調べ、まとめました。種類別セグメントは、兄弟DNA検査、祖父母検査、遺伝子再構成検査、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。DTC関係検査の世界市場概観、企業動向、企業別DTC関係検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・DTC関係検査の市場概観 ・DTC関係検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・DTC関係検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・DTC関係検査の世界市場規模 ・DTC関係検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・DTC関係検査のアメリカ市場規模推移 ・DTC関係検査のカナダ市場規模推移 ・DTC関係検査のメキシコ市場規模推移 ・DTC関係検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests can indicate whether tested individuals are biologically related to one another. For example, kinship testing can establish whether one person is the biological father of another (paternity testing). Scope of the Report: The global Direct-to-consumer Relationship Tests market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The...
  • DTC関係遺伝子検査の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102760 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、DTC関係遺伝子検査の世界市場について調べ、まとめました。種類別セグメントは、兄弟DNA検査、祖父母検査、遺伝子再構成検査、その他等、用途別セグメントは、オンライン、オフライン等に区分しました。DTC関係遺伝子検査の世界市場概観、企業動向、企業別DTC関係遺伝子検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・DTC関係遺伝子検査の市場概観 ・DTC関係遺伝子検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・DTC関係遺伝子検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・DTC関係遺伝子検査の世界市場規模 ・DTC関係遺伝子検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・DTC関係遺伝子検査のアメリカ市場規模推移 ・DTC関係遺伝子検査のカナダ市場規模推移 ・DTC関係遺伝子検査のメキシコ市場規模推移 ・DTC関係遺伝子検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The results of these tests can indicate whether tested individuals are biologically related to one another. For example, kinship testing can establish whether one person is the biological father of another (paternity testing). Scope of the Report: The global Direct-to-consumer Relationship Genetic Tests market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially...

    • ◆H&Iグローバルリサーチのお客様（例）◆